Dr Adebayo Ogunjimi
Adebayo is a technology Transfer Consultant. He previously managed a team of engineering technology developers before going to run his own consultancy business.
He works with City, University of London inventors to prepare a commercialisation pack and implement the appropriate commercialisation route.
Alan is a Trustee & Treasurer of RNIB Group and Chair of its Audit & Investment Committees. He is Chair of LOCSU, Director of FODO, a member of OCLG, and a Trustee of Action for Blind People. His previous roles include directorships of listed companies including a major opticians group. He was MD & part-owner of Galaxy Optical, to which Tesco outsources their opticians supply chain.
LEO Innovation Lab
Catalina is Head of the UK Innovation Lab, an independent unit established by LEO Pharma as part of a long-term strategy to focus on patient centric solutions. She was previously a business strategist at DigitasLBi, Director of ZappiStore, and Managing Director of Spring Research, and has an MBA from Oxford's Said Business School.
Professor Chris Dainty
UCL Institute of Opthalmology
Chris is Professorial Research Associate, UCL Institute of Ophthalmology. He is a Fellow of The Optical Society of America, SPIE, The Institute of Physics (UK) and The European Optical Society.
Thomas Pocklington Trust
Chris is a Partnership Manager for the Pocklington Trust. He is the patient representative on the advisory board for the “Future of Healthcare: Computerisation, Automation, and GP Services” project at the University of Oxford. Chris is part of the London research group of the ARCHES.
Chris Mairs CBE
Chris is an early-stage investor in high-tech start-ups with a portfolio comprising 50+ companies. He is a Fellow of RAENG and British Computer Society, a trustee of the Raspberry Pi Foundation and a Venture Partner at both Entrepreneur First and Beacon Capital.
Duncan's experience includes the development of both healthcare products & their manufacturing systems, including medical devices for the treatment of the eye, and ophthalmic drug delivery. Duncan has worked with some of the world's largest healthcare companies, along with many startups.
Prior to Cambridge Consultants, Duncan spent 19 years in the Engineer Branch of the RAF.
Florence is responsible for innovation and new income generation at RSBC. She is a co-founder of Wayfindr, an audio navigation system for vision impaired people that enables them to navigate within a built environment using their smartphone.
Ian is an optician, an author of 6 books, one DVD and CDRom. He is an inventor and internationally recognised speaker. Ian collaborates with well-known lighting companies, universities, and optical companies. He was the first person to fit contact lenses for dyslexia, and the first to propose light intervention for prosopagnosia.
Inga is a Principal in the Healthcare Ventures team, specialising in investments across medical devices, therapeutics, diagnostics, and healthcare, including digital health. She is currently a Director at Puridify and Ieso Digital Health and a board observer at Veryan Medical.
She completed a DPhil and MSc in Neuroscience from the University of Oxford, sponsored by the Wellcome Trust.
Working within RNIB Solutions, John acts as a catalyst to innovation, drawing on his technical and R&D experiences.
John managed RNIB’s work on emerging travel tech to remove the barriers faced by blind and partially sighted when making journeys.
Katrina manages the Clearly Social Angels, the UK’s most proactive impact angel investor network, and helps catalyse their private investment into high-impact businesses ClearlySo advises. She currently advises international start-up NextDayBetter and was previously chairman of London-based NGO Philippine Generations.
Ananda Social Venture Fund
Lennart is Investment Director at Ananda, responsible for their UK operations. He began his career at JP Morgan, before moving on to derivative trading & structuring. He then founded his own company. His strong interest in early stage companies led him to become an investment manager at the Foundation for Social Entrepreneurs - UnLtd.
The Pacello Group
Léonie is Communications Director & Principal engineer at the Pacello Group. Among other things, she is a cochair of the W3C Web Platforms working group and a member of the ARIA Working Group.
In her spare time, Léonie blogs on Tink.uk and writes for Smashing magazine, SitePoint.com, and Net magazine.
University of Liverpool
Louis is an Consultant Ophthalmic Surgeon and medico legal expert. He is also working on a number of eye-care startups, such as EyeCalm and EyeWarm, and has significant experience developing new products in an NHS setting.
Dr Manbir Nagra
Dr Nagra is currently an optometry lecturer at City University. She completed her PhD at Aston University, and then worked as a postdoctoral visual scientist. Her research interests include myopia development, ocular biometry, and myopia control.
Mark is CEO of IbisVision, a company developing
unique software for visual field tests. He provides a wealth of experience in commercial & strategic development having managed, consulted and acted at executive and non executive director level for numerous IT companies over the last 12+ years.
Matt is CEO & Co-Founder of health-tech startup Healthforge, which provides tools for building health apps and services. Previously Matt was part of the team that built the Electronic Patient Record system for Moorfields Eye Hospital, and an analyst in the pharma sector.
Michael is CEO of Thomson Screening, a spin-out company from City University. Michael was CEO of the Map of Medicine (UCL) and is a director of Virtual Tutor (City University). Previous experience includes Development Director of DMG Information, an investor in education and information software businesses.
Paul heads up the BBC's Assistive Technology service, which works throughout the BBC to ensure, not only that all staff facing technologies are accessible to all, but also that the assistive technology service meets the need of all users. A crucial part of his role is to set the BBC's strategy for assistive technology hardware, software, and devices (e.g.mobile, tablet).
Bethnal Green Ventures
Paul is a partner at Bethnal Green Ventures where he leads their strategy and partnerships. He was previously co-founder and CEO of education technology startup School of Everything as well as working for the think tanks Demos and Forum for the Future.
Dr Pearse Keane
Moorfields Eye Hospital
Pearse is a consultant ophthalmologist at Moorfields and an NIHR Clinician Scientist, based at the Institute of Ophthalmology, UCL. He specialises in applied ophthalmic research. In April 2015, Pearse was ranked no. 4 on a worldwide ranking of ophthalmologists under 40. In 2016, he initiated a formal collaboration between Moorfields and DeepMind.
Rafiq Hasan is VP & Global Head of Ophthalmology at Bayer. Rafiq trained as a doctor in London and following 3 years clinical practice entered the pharma industry. He has worked in a variety of roles both in the UK and internationally. Prior to joining Bayer, Rafiq was global head of Ophthalmology at Novartis Pharma AG.
Robin is Principal Manager, Digital Accessibility at RNIB where he leads a team of accessibility specialists in a range of international commercial partnerships.
Robin is a presenter/producer of the popular AccessTalk podcast and is Vice Chair of Vision 2020 UK Tech for Life Working Group.
Deepbridge Capital LLP
Savvas Neophytou is a partner of Deepbridge Capital, investing in early stage tech companies. Previously he was a founding shareholder of tech companies including Torafugu and Cerneretec. He was also CEO of Dr Now, an online doctor platform. Prior to that Savvas had a long career in the City.
Steven is Connect Content Manager at RNIB. His role is to work with blind and partially sighted people to ensure their voice is heard through the charity's various channels, including radio station RNIB Connect Radio. Steven has almost 20 years experience in the broadcast industry, and has lived with four separate eye problems since he was a baby.
Thomas is a co-founder, CEO and a Board member of Oxular. He was formerly co-founder and President of Aciex Therapeutics, where he brought its lead programme to NDA, oversaw development of a novel API technology, and led a successful M&A exit in 2014. He has worked in roles related to capital raises, M&A transactions, industry consolidations, strategic planning, and post-merger integration.
Tram is founder & CEO of VITAnLINK that partners with early-stage health-tech ventures to identify go-to-market shortcuts, and gain first mover’s advantage in international markets.She currently serves on the board of Dreamup Vision (Board Director), the CEPS eHealth Club think tank, the Ivy Plus European Leaders, and is the Founding Board Member of the Avenir Femmes Santé Women’s Health Association.
The conference will run from 9am - 7pm with a mix of keynotes, discussion panels, and pitches from EyeFocus companies. During lunch and coffee breaks companies will be demonstrating their products and holding investor meetings.
09:00-09:45 - Registration
09:45-10:00 - Opening Speech from EyeFocus, Bayer HealthCare & RAENG
10:00-10:10 - Introduction from RNIB
10:10-10:40 - Translating Innovation - What People Need And Use
With the three leading UK charities supporting people who are blind and visually impaired, this panel will discuss how they are using innovation and technology to help people live with and manage their conditions.
10:40-11:00 - Pitch Session
(Wayfindr, FaTHER Equipment, Eye-D)
11:00-11:30 - Coffee Break
11:30-12:10 - Investment: From Profit to Impact
The panel will look at the range of investment approaches from Impact to pure commercial, and how the two can converge to create for profit, commercial investments with social outcomes. VC fund Ananda runs the Social Impact Fund, ClearlySo is an impact investment firm running the UK’s leading Impact Angel group, Bethnal Green Ventures run the UK’s leading Social Venture accelerator, and DeepBridge Capital is a VC fund investing in healthcare.
12:10-12:30 - Pitch Session
(BLOO Vision, Okimo, Arthur's Eyes)
12:30-13:00 - Commercialisation: Taking Ideas to Market
Professor Chris Dainty, Catalina Cernica, Tram Trinh, and Matt Hartley will explore the journey startups make to take ideas to market. Tram advises eye-care and med-tech companies on commercialisation, and Matt is the founder of HealthForge, which has successfully raised investment and taken their health tech product to market this year.
13:00-14:30 - Lunch
14:30-15:00 - Companies Spinning Out of Universities - Opportunities And Obstacles
This panel will bring together eye-care startups who have spun out of university or clinical settings, to talk about their experiences building a company from this starting point. Panelists will examine some of the obstacles and opportunities, and the journey of going from a research project to a fully-fledged business.
15:00-15:20 - Pitch Session
(MAG Optics, Thomson Screening, DB Glove)
15:20-15:50 - Old Meets New - The Victorian Charity Advising Silicon Valley Giants
This panel will look at the work that RNIB, the BBC, and the Pacello Group do in supporting the development of cutting edge tech, from advising Apple in accessibility issues, through to developing BBC iPlayer.
15:50-16:10 - Pitch Session
(EyeCalm, 3 Clouds, 20/20 Optimeyes, 6over6)
16:10-16:30 - Coffee Break
16:30-16:45 - Pitch Session
(EyeYon Medical, Plenoptika)
16:45-17:30 - The Big Business of Eye-Care
This panel discussion will be focusing on funded startups that are becoming big businesses in the eye-care sector.
17:30-17:45 - Closing Talk with EyeFocus and Bayer Healthcare
17:45-19:00 - Networking
These EyeFocus participants will be pitching in person and by video
Okimo has built a mobile cross-platform app that enables patients suffering from strabismus and amblyopia to carry out their daily therapy exercises at home, and to monitor their progress.
PlenOptika is disrupting the barriers to eyeglasses/eyeglass prescription for billions of people worldwide with our device, the QuickSee. The QuickSee is a low-cost, handheld device that allows anyone to accurately and reliably identify the eyeglasses needed for vision correction with the push of a button.
FaTHER are developing a digital haptic device to fit to white sticks to assist visually impaired people to navigate easily around cities. (Feel The Route) is directed to targeted consumer, and will be delivered either directly or via NGOs / Government agencies that support the visually impaired or senior citizens.
MAG Optics Ltd, is an emerging ophthalmic medical device company, focusing on the research and development of Intraocular Lens (IOL) and corneal implants. We are headquartered in the UK.
BLOO is the new, non-invasive, binocular training for lazy eye (amblyopia). BLOO's system was developed around 3 key targets, "effective", "efficient" and "economical."
Wayfindr is a non-profit organisation, that was founded as a direct result of work done by the Royal London Society for Blind People’s (RLSB) Youth Forum and ustwo in 2014. They are creating a benchmark in standards for digital wayfinding on mobile devices. Their aim is to empower vision impaired people to overcome isolation, through audio based navigation.
EyeCalm, developed with Liverpool University, is a clinician-led clinical decision support app that accurately identifies dry eye syndrome - one of the commonest ocular maladies worldwide. Eyecalm explains to patients why they are suffering their symptoms and symptoms control based on accepted best practice.
Thomson Screening, a company formed by City University London, is at the forefront of developing software to manage vision, hearing and height/weight screening in schools. Their SchoolScreener software is in use in the UK, USA, Europe, Australia and Africa providing cost effective, high quality screening.
3Cloud by Yumé is a soothing thermal therapy, designed to help relieve dry, puffy and tired eyes. Easy to use. Friendly for Travel. Foundational for your eye health. This hardware device addresses problems with tear ducts and dry eye.
EyeYon Medical is a start-up company specializing in developing medical ophthalmic devices offering unique solutions for complications resulting from various corneal diseases, including corneal edema. Eye-Yon Medical provides innovative, patent protected solutions that proved feasibility for corneal healing, including corneal edema.
Eye-D app is an accessible app with provides visually impaired interfaces. The app can be used by visually impaired across the globe to be location aware, explore and navigate nearby places of interest. It also helps them in evaluating surroundings by identifying objects, reading text labels, newspaper, forms etc. The app is capable of interpreting objects and text from images shared with it. Eye-D Keypad (patent pending) is world first portable accessible wireless keypad that attaches with smartphones of any screen size and compatible all android smartphones.
6over6 delivers a novel digital / mobile health platform that allows every user to get their required prescription using their smartphone: our ground breaking mobile application provides the same functionality found in every optometrist clinic.
20/20 Optimeyes develops transformative solutions for ocular diseases that would improve the quality of life for millions of patients worldwide. Currently, Optimeyes is advancing the commercialization of a patented solution to treat dry eye disease (DED), which affects over 5 million Americans based on recent studies. Based on industrial feedback, Optimeyes is de-risking a mucoadhesive, polymeric micelle containing cyclosporine A, an off-patent drug currently used in DED treatments, by completing pre-clinical and phase 1 clinical trials.
Arthur’s Eye is focused on vision training for strabismic amblyopia in children and the young - within the context of a distributed citizen science experiment. They are actively participating in research uncovering the neuroscience of vision, whilst broadening the awareness and acceptance of vision training as a necessary and important aspect of treatment for amblyopia within the medical community.